Malignant transformation of human prostatic epithelium is associated with the loss of androgen receptor immunoreactivity in the surrounding stroma

Clinical Cancer Research

Volumn 5, Issue 3, 1999, Pages 569-576

  Olapade Olaopa, E Oluwabunmi ^a   MacKay, E Hugh ^a   Taub, Nicholas A ^b   Sandhu, Davinder P S ^a   Terry, Timothy R ^a   Habib, Fouad K ^c  

^a LEICESTER GENERAL HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

^c WESTERN GENERAL HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; ANDROGEN RECEPTOR;

ARTICLE; CANCER GRADING; CANCER GROWTH; CELL DIFFERENTIATION; CONTROLLED STUDY; DISEASE ASSOCIATION; HORMONAL REGULATION; HORMONE RESISTANCE; HORMONE SENSITIVITY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; PROSTATE CANCER; PROSTATE EPITHELIUM; PROSTATE HYPERTROPHY; REGULATORY MECHANISM;

CARCINOMA; CELL TRANSFORMATION, NEOPLASTIC; EPITHELIUM; HUMANS; IMMUNOASSAY; MALE; NEOPLASM METASTASIS; PROSTATIC HYPERPLASIA; PROSTATIC INTRAEPITHELIAL NEOPLASIA; PROSTATIC NEOPLASMS; RECEPTORS, ANDROGEN; STROMAL CELLS;

EID: 0033000237     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (26)

1. Sar, M., Lubhan, D. B., Franch, F. S., and Wilson, E. M. Immunohistochemical localisation of the androgen receptor in rat and human tissues. Endocrinology, 127: 3180-3186, 1990.
2. Barrack, E. R., and Tindall, T. J. A critical evaluation of the use of androgen receptor assays to predict the androgen responsiveness of prostate cancer. Prog. Clin. Biol. Res., 239: 155-187, 1987.
3. Chodak, G. W., Kranc, D. M., Puy, L. A., Takeda, H., Johnson, K., and Chang, C. Nuclear localization of androgen receptor in hetrogeneous samples of normal, hyperplastic and neoplastic human prostate. J. Urol., 147: 796-803, 1992.
4. Masai, M., Sumiya, H., Akimoto, S., Yatani, R., Chang, C. S., Liao, S. S., and Shimazaki, J. Immunohistochemical study of androgen receptor in benign hyperplastic and cancerous human prostates. Prostate, 17: 293-300, 1990.
5. Magi-Galluzzi, C., Xu, X., Hlatky, L., Hahnfeldt, P., Kaplan, I., Hsiao, P., Chang, C., and Loda, M. Heterogeneity of androgen receptor content in advanced prostate cancer. Mod. Pathol., 10: 839-845, 1997.
6. Ruizeveld de Winter, J. A., Janssen, P. J. A., Sleddens, H. M. E. B., Verleun-Mooijman, M. C. T., Trapman, J., Brinkman, A. O., Santerse, A. B., Schroder, F. H., and van der Kwast, T. H. Androgen receptor status in localized and locally progressive hormone refractory human prostate cancer. Am. J. Pathol., 144: 735-746, 1994.
7. Koivisto, P., Konomen, J., Palmberg, C., Tammela, T., Hyytinen, E., Isola, J., Trapman, J., Cleutjens, K., Noordzij, A., Visakorpi, T., and Kallioniemi, O-P. Androgen receptor gene amplification: a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer. Cancer Res., 57: 314-319, 1997.
8. Visakorpi, T., Hyytinen, E., Koivisto, P., Tanner, M., Keinamen, R., Palmberg, C., Palotie, A., Tammela, T., Isola, J., and Kallioniemi, O-P. In vivo amplification of the androgen receptor gene and progression of human prostate cancer. Nat. Genet., 9: 401-406, 1995.
9. Hiramatsu, M., Kashimata, M., Minami, N., Sato, A., and Murayama, M. Androgenic regulation of epidermal growth factor in the mouse ventral prostate. Biochem. Int., 17: 311-317, 1988.
10. Brass, A. L., Barnard, J., Patai, B. L., Saivi, D., and Rukstalis, D. B. Androgen up-regulates epidermal growth factor receptor expression and binding affinity in PC3 cell lines expressing the human androgen receptor. Cancer Res., 55: 3197-3203, 1995.
11. Shima, H., Tsuji, M., Elfman, F., and Cunha, G. R. Development of the male urogenital epithelia elicited by soluble mesenchymal factors. J. Androl., 16: 233-241, 1995.
12. Gleason, D. F., Mellinger, G. T., and the Veterans Administration Cooperative Urological Research Group. Prediction of prognosis for prostate adenocarcinoma by combined histological grading and clinical staging. J. Urol., 111: 58-64, 1974.
13. Loda, M., Fogt, F., French, F. S., Posner, M., Cukor, B., Aretz, H. T., and Alsaigh, N. Androgen receptor immunohistochemistry on paraffin-embedded tissue. Mod. Pathol., 7: 388-391, 1994.
14. Olapade-Olaopa, E. O., MacKay, E. H., and Habib, F. K. Variability of immunohistochemical reactivity on stored paraffin slides. J. Clin. Pathol., 51: 945, 1999.
15. Miyamoto,K. K., McSherry, S. A., Dent, G. A., Sar, M., Wison, E. M., French, F. S., Sharief, Y., and Mohler, J. L. Immunohistochemistry of the androgen receptor in human benign and malignant prostate tissue. J. Urol., 149: 1015-1019, 1993.
16. Haggman, M. J., Wojno, K. J., Pearsall, C. P., and Macoska, J. A. Alleilic loss of 8p sequences in prostatic intraepithelial neoplasia and carcinoma. Urology, 50: 643-647, 1997.
17. van der Kwast, T. H., Tetu, B., Fradet, Y., Dupont, A., Gomez, J., Cusan, L., Diamond, P., and Labrie, F. Androgen receptor modulation in benign human and prostatic adenocarcinoma during neoadjuvant endocrine combination therapy. Prostate, 28: 227-231, 1996.
18. Leav, I., McNeal, J. E., Kwan, P. W-L., Komminoth, P., and Merk, F. B. Androgen receptor expression in prostatic dysplasia (prostatic intraepithelial neoplasia) in the human prostate: an immunohistochemical and in situ hybridisation study. Prostate, 29: 137-145, 1996.
19. Veldsholte, J., Ris-Stalpers, C., Kuiper, G. G. J. M., Jenster, G., Berrevoets, C., Claasen, E., van Rooji, H. C. J., Trapman, J., and Brinkman, A. O. A mutation in the ligand binding domain of the androgen receptor of human LNCaP cells affects steroid binding characteristics and response to anti-androgens. Biochem. Biophys. Res. Commun., 17: 534-540, 1990.
20. Newark, J. R., Hardy, D. O., Tonb, D. C., Carter, B. S., Epstein, J. I., Isaacs, W. B., Brown, T. R., and Barrack, E. R. Androgen receptor gene mutations in human prostate cancer. Proc. Natl. Acad. Sci. USA, 89: 6319-6323, 1992.
21. Suzuki, H., Sato, N., Watabe, Y., Masai, M., Seino, S., and Shimazaki, J. Androgen receptor gene mutations in human prostate cancer. J. Steroid Biochem. Mol. Biol., 46: 759-763, 1993.
22. Goldenberg, D. M., and Pavia, R. A. Malignant potential of murine stromal cells after transplantation of human tumors into nude mice. Science (Washington DC), 212: 65-67, 1981.
23. Pathak, S., Nemeth, M. A., Multani, A. S., Thalmann, G. N., von Eschenbach, A. C., and Chung, L. W. K. Can cancer cells transform normal host cells into malignant cells? Br. J. Cancer, 76: 1134-1138, 1997.
24. Chung, L. W. K., Cleave, M. E., Hsieh, J-T., Hong, S-J., and Zhau, H. E. Reciprocal mesenchymal-epithelial interaction affecting prostatic tumour growth and hormonal responsiveness. Cancer Surv., 11: 92-121. 1991.
25. Gregoire, M., and Lienbeau, B. The role of fibroblasts in tumor behaviour. Cancer Metastasis Rev., 14: 323-338, 1995.
26. Radinsky, R. Modulation of tumor cell gene expression and phenotype by the organ-specific metastatic environment. Cancer Metastasis Rev., 14: 339-350, 1995.